GENERAL30 Sept 2026
How Anupam Rasayan plans to double Bliss GVS Pharma's rev in three years - CNBC TV18
Anupam Rasayan India plans to double the revenue of Bliss GVS Pharma, its latest acquisition, in three years. Deputy Chief Financial Officer Vishal Thakkar shared this plan with CNBC-TV18. The company aims to scale up the acquired business. For suppliers, buyers, and investors in these two firms, it points to growth ahead. Wait for official updates before taking any decision.
Key Statutory Highlights
- Anupam Rasayan India wants to double the revenue of Bliss GVS Pharma within three years.
- Bliss GVS Pharma is the latest acquisition made by Anupam Rasayan India.
- Deputy Chief Financial Officer Vishal Thakkar shared these plans in an interview with CNBC-TV18.
Actionable Advice for Taxpayers / Founders:If you deal with either company as a supplier, buyer, or investor, treat this as an early plan only. Wait for official company announcements or filings before you change any contract, order, or investment decision.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: